Products

Therapeutic indications

(Non-reimbursement) Indicated in adults for luteal support as part of an Assisted Reproductive Technology (ART) treatment program in infertile women who are unable to use or tolerate vaginal preparations.

Posology and method of administration

(Non-reimbursement) Once daily injection of 25 mg from day of oocyte retrieval, usually until 12 weeks of confirmed pregnancy.
Choose an appropriate area (front of thigh, lower abdomen), swab proposedarea, pinch the skin together firmly and insert the needle at an angle of 45° to 90°. The product should be injected slowly to minimise local tissue damage. Each pre-filled syringe is intended for single-use injection only.

Package and containing

1 pre-filled syringe X 7

Precautions for storage

Store at room temperature (1-30°C). Do not refrigerate or freeze.
Store in the original package in order to protect from light.

Shelf life

2 years (24 months from the date of manufacture)

Inquiries about the product

T. +82-2-711-0141~2

Inquiries and report on adverse events (AEs)

pv@izenpharma.com

※ For more information, please refer to the insert paper.